162 related articles for article (PubMed ID: 25920034)
1. Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?
Lidani KC; Beltrame MH; Luz PR; Sandri TL; Nisihara RM; de Messias-Reaso IJ
Int J Cardiol; 2015; 190():233-5. PubMed ID: 25920034
[No Abstract] [Full Text] [Related]
2. Serum pentraxin-3 levels in acute stroke: No association with stroke prognosis.
Ceylan M; Yalcin A; Bayraktutan OF; Atis O; Acar E
Atherosclerosis; 2015 Dec; 243(2):616-20. PubMed ID: 26546709
[TBL] [Abstract][Full Text] [Related]
3. Increased serum pentraxin-3 levels; a novel cardiovascular marker.
Varol E
Turk Kardiyol Dern Ars; 2013 Jun; 41(4):296-8. PubMed ID: 23760116
[No Abstract] [Full Text] [Related]
4. Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients.
Zineldeen DH; Keshk WA; Ghazy AH; El-Barbary AM
Ann Clin Biochem; 2016 Mar; 53(Pt 2):240-51. PubMed ID: 25732129
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3 and C-reactive protein as inflammatory markers after a kidney transplant.
Gursu M; Celik K; Ozturk S; Turkmen A; Gorcin S; Kocak B; Sari S; Koldas M; Feyizoglu H; Kazancioglu R
Exp Clin Transplant; 2014 Aug; 12(4):295-9. PubMed ID: 24568622
[TBL] [Abstract][Full Text] [Related]
6. Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Nishi K; Imamura T; Kitamura K; Ogawa T; Fujimoto S; Kakitsubata Y; Ishikawa T; Asada Y; Kodama T
Ren Fail; 2011; 33(4):398-404. PubMed ID: 21529268
[TBL] [Abstract][Full Text] [Related]
7. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.
Tong M; Carrero JJ; Qureshi AR; Anderstam B; Heimbürger O; Bárány P; Axelsson J; Alvestrand A; Stenvinkel P; Lindholm B; Suliman ME
Clin J Am Soc Nephrol; 2007 Sep; 2(5):889-97. PubMed ID: 17702732
[TBL] [Abstract][Full Text] [Related]
8. Is pentraxin 3 a new cardiovascular risk marker in polycystic ovary syndrome?
Sari U; Kaygusuz I; Kafali H
Gynecol Obstet Invest; 2014; 78(3):173-8. PubMed ID: 25011417
[TBL] [Abstract][Full Text] [Related]
9. Changes in circulating biomarkers during a single hemodialysis session.
Yamamoto T; Nascimento MM; Hayashi SY; Qureshi AR; Waniewski J; Brodin LÅ; Anderstam B; Lind B; Riella MC; Seeberger A; Lindholm B
Hemodial Int; 2013 Jan; 17(1):59-66. PubMed ID: 22716238
[TBL] [Abstract][Full Text] [Related]
10. Serum pentraxin 3 is a novel marker in Crohn's disease.
Chen J; Xu X; Xia L; Xi X; Liu B; Yang M
Mol Med Rep; 2015 Jul; 12(1):543-6. PubMed ID: 25760650
[TBL] [Abstract][Full Text] [Related]
11. [A novel cardiovascular marker: pentraxin 3].
Inoue K
Nihon Rinsho; 2010 Jul; 68 Suppl 7():862-5. PubMed ID: 20960887
[No Abstract] [Full Text] [Related]
12. [Endothelial function and high-sensitivity C-reactive protein levels in patients with Chagas disease living in a nonendemic area].
García-Álvarez A; Sitges M; Heras M; Poyatos S; Posada E; Pinazo MJ; Regueiro A; Gascon J; Sanz G
Rev Esp Cardiol; 2011 Oct; 64(10):891-6. PubMed ID: 21802190
[TBL] [Abstract][Full Text] [Related]
13. Association of IP-10 and PDGF-BB levels with clinical forms of chronic Chagas disease.
Luz PR; Velavan TP; Kremsner PG; Messias-Reason IJ
Int J Cardiol; 2013 Nov; 169(4):e53-5. PubMed ID: 24182907
[No Abstract] [Full Text] [Related]
14. Relationship between pentraxin 3 levels of the mothers with preterm premature rupture of membranes and their neonates.
Agilli M; Aydin FN; Kurt YG; Cayci T
J Matern Fetal Neonatal Med; 2015; 28(17):2040. PubMed ID: 25357242
[No Abstract] [Full Text] [Related]
15. Prognostic value of serum pentraxin 3 for intracerebral hemorrhage mortality.
Hao PH; Fu C; Ma T; He SM; Jia ZP
J Integr Neurosci; 2021 Mar; 20(1):137-142. PubMed ID: 33834701
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population: a methodological approach.
Agilli M; Aydin FN; Cayci T; Kurt YG
Nutr Metab Cardiovasc Dis; 2014 Dec; 24(12):e38-9. PubMed ID: 25304608
[No Abstract] [Full Text] [Related]
17. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.
Hudzik B; Danikiewicz A; Szkodzinski J; Polonski L; Zubelewicz-Szkodzinska B
Eur Cytokine Netw; 2014; 25(3):41-5. PubMed ID: 25373851
[TBL] [Abstract][Full Text] [Related]
18. ADENOSINE DEAMINASE ACTIVITY AND SERUM C-REACTIVE PROTEIN AS PROGNOSTIC MARKERS OF CHAGAS DISEASE SEVERITY.
Bravo-Tobar ID; Nello-Pérez C; Fernández A; Mogollón N; Pérez MC; Verde J; Concepción JL; Rodriguez-Bonfante C; Bonfante-Cabarcas R
Rev Inst Med Trop Sao Paulo; 2015; 57(5):385-92. PubMed ID: 26603224
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity.
Mauri T; Coppadoro A; Bellani G; Bombino M; Patroniti N; Peri G; Mantovani A; Pesenti A
Crit Care Med; 2008 Aug; 36(8):2302-8. PubMed ID: 18596636
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma pentraxin 3: a potential cardiovascular risk factor?
Liu Q; Tu T; Bai Z; Liu Z; Zhou S
Med Hypotheses; 2011 Dec; 77(6):1068-70. PubMed ID: 21944885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
